E Fund Management Co., Ltd. - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$243
-38.3%
11,781
-11.8%
0.02%
-41.9%
Q2 2023$394
+16.9%
13,361
-8.6%
0.03%
+24.0%
Q1 2023$337
-18.4%
14,619
-1.6%
0.02%
-26.5%
Q4 2022$413
-99.9%
14,861
+4.3%
0.03%
-17.1%
Q3 2022$437,000
+27.4%
14,254
+22.4%
0.04%
+32.3%
Q2 2022$343,000
+20.8%
11,641
+31.9%
0.03%
+244.4%
Q1 2022$284,0008,8270.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders